What is the appropriate evaluation and management for a patient with splenomegaly, mild hepatic steatosis, and a 3.4 × 3.1 × 2.4 cm calcified right paratracheal lymph node?

Evaluation and Management of Splenomegaly, Hepatic Steatosis, and Calcified Paratracheal Lymph Node

Immediate Priority: Hematology Referral

This patient requires urgent hematology referral as the first-line evaluation, because myeloproliferative neoplasms are the most common cause of splenomegaly in developed countries and can present with concurrent hepatic steatosis. 1

Critical Initial Assessment

Splenomegaly Evaluation

• Measure spleen size precisely on imaging to determine if this represents massive splenomegaly (>20 cm below left costal margin or >10 cm on physical examination), which warrants expedited hematology referral 1
• Obtain complete blood count immediately to assess for cytopenias indicating hypersplenism or myeloproliferative disorders; note that normal CBC does not exclude myeloproliferative neoplasms 1
• Assess for palpable splenomegaly on physical examination; if spleen is palpable involving >3% of abdominal examination, this essentially excludes immune thrombocytopenic purpura and requires alternative investigation 1

Life-Threatening Exclusions

• Rule out cirrhosis with portal hypertension immediately, as splenic artery aneurysm rupture in this setting carries 70-95% mortality 2
• Examine for clinical signs of chronic liver disease including jaundice, ascites, spider angiomas, palmar erythema, and caput medusae to identify portal hypertension 1
• Assess for signs of portal hypertension including esophageal varices, ascites, and lower extremity edema 3

Hepatic Steatosis Work-Up

Risk Stratification for Fibrosis

• Calculate Fibrosis-4 (FIB-4) index using age, AST, ALT, and platelet count as the initial non-invasive test for fibrosis risk stratification 4
• If FIB-4 is indeterminate or high, proceed to liver stiffness measurement by transient elastography (vibration-controlled transient elastography) 4
• Assess for metabolic risk factors including obesity (BMI, waist circumference), type 2 diabetes or prediabetes (fasting glucose, HbA1c), hypertension, and dyslipidemia (triglycerides, HDL cholesterol) 4

Exclude Alternative Causes

• Quantify alcohol consumption using validated questionnaires; significant consumption is defined as ≥21 drinks/week in men or ≥14 drinks/week in women 4
• Screen for viral hepatitis (hepatitis B surface antigen, hepatitis C antibody) 4
• Test for hemochromatosis if ferritin and transferrin saturation are elevated (HFE gene mutation testing) 4
• Check autoimmune markers (ANA, anti-smooth muscle antibody) and ceruloplasmin to exclude Wilson disease, particularly given splenomegaly which may indicate clinically inapparent cirrhosis 4, 2
• Review medication list for steatosis-inducing drugs (corticosteroids, tamoxifen, methotrexate) 5

Hepatology Referral Indications

• Refer to hepatology if clinical signs of chronic liver disease are present, FIB-4 indicates significant fibrosis risk, or liver stiffness measurement suggests advanced fibrosis (≥8.0 kPa) 4, 1
• Immediate hepatology referral is mandatory if hepatosplenomegaly is present, as early intervention can prevent progression of liver fibrosis 2

Calcified Paratracheal Lymph Node Evaluation

Determine Clinical Significance

• Calcified lymph nodes at 3.4 cm are abnormal and require tissue diagnosis to exclude malignancy, particularly given the size exceeds typical benign calcification 4
• Consider that paratracheal lymph nodes can harbor metastatic disease from various primary sites, including occult lung adenocarcinoma even without visible pulmonary nodules 6
• Assess for primary malignancy with chest CT (if not already performed), looking specifically for pulmonary nodules, mediastinal masses, or thyroid abnormalities 6

Diagnostic Approach

• PET/CT is appropriate for metabolic characterization of the lymph node if malignancy is suspected, though calcification may reduce FDG avidity 4
• Image-guided transthoracic needle biopsy or mediastinoscopy should be considered for tissue diagnosis if imaging suggests malignancy or if the node enlarges on surveillance 4
• Surveillance imaging at 3-6 months is reasonable if clinical suspicion for malignancy is low and the patient has no risk factors for lung cancer 4

Common Benign Causes

• Granulomatous disease (prior tuberculosis, histoplasmosis, sarcoidosis) is the most common cause of calcified mediastinal lymph nodes 7
• Obtain tuberculin skin test or interferon-gamma release assay and fungal serologies if endemic exposure history is present 1

Infectious Disease Considerations

• Obtain detailed travel history to malaria-, schistosomiasis-, or leishmaniasis-endemic regions, as parasitic infections are common causes of splenomegaly in tropical areas 1, 8
• If travel history is positive, refer to infectious disease for evaluation with appropriate serologies and smears 1
• Assess for endocarditis risk factors (fever, new murmur, injection drug use) as endocarditis can cause splenic abscess and splenomegaly 2, 1

Genetic/Metabolic Evaluation

• Consider lysosomal storage diseases if massive hepatosplenomegaly (>10× normal size) is present with bone or joint pain, particularly acid sphingomyelinase deficiency (Niemann-Pick disease) 1
• Refer to medical genetics if family history of lysosomal storage disorders, consanguinity, or unexplained organomegaly is present 1

Monitoring and Complications Prevention

Surveillance Strategy

• Perform serial complete blood counts to monitor for worsening cytopenias indicating progressive hypersplenism 3
• Repeat imaging periodically to monitor spleen size and detect complications such as splenic infarction or rupture 3
• Monitor for signs of portal hypertension including development of varices, ascites, or hepatic encephalopathy 3

Infection Prevention

• Vaccinate against encapsulated bacteria (pneumococcal, Haemophilus influenzae type b, meningococcal vaccines) given increased infection risk with splenomegaly 3
• Provide annual influenza vaccination 3
• Counsel on avoiding contact sports to decrease risk of traumatic splenic rupture 8
• Educate on signs of overwhelming infection (fever, rigors, altered mental status) requiring immediate medical attention 3

Critical Pitfalls to Avoid

• Do not delay hematology referral based on normal CBC, as myeloproliferative disorders can present with normal blood counts initially 1
• Do not assume hepatic steatosis is benign NAFLD/MASLD without excluding cirrhosis, as portal hypertension with splenomegaly indicates advanced liver disease 4, 2
• Do not dismiss the calcified lymph node as benign without considering occult malignancy, particularly lung adenocarcinoma which can metastasize to paratracheal nodes without visible primary tumor 6
• Do not overlook Wilson disease in younger patients with unexplained splenomegaly and hepatic steatosis, as it may present with isolated splenomegaly from clinically inapparent cirrhosis 2